Agilent Technologies (BSP:A1GI34) Total Current Assets : R$21,335 Mil (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Agilent Technologies Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Agilent Technologies's total current assets for the quarter that ended in Jan. 2024 was R$21,335 Mil.

Agilent Technologies Total Current Assets Historical Data

The historical data trend for Agilent Technologies's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Total Current Assets Chart

Agilent Technologies Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Current Assets

Get a 7-Day Free Trial

13,019.09

19,210.40

21,052.54

19,842.43

21,164.00

Agilent Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Current Assets	Get a 7-Day Free Trial															21,173.79	19,829.90	19,346.02	21,164.00	21,335.15

Agilent Technologies Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Agilent Technologies's Total Current Assets for the fiscal year that ended in Oct. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	8038.881	+	6527.167	+	5212.633	+	1385.316
	=	21,164

Agilent Technologies's Total Current Assets for the quarter that ended in Jan. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	8597.014	+	6369.069	+	5080.501	+	1288.568
	=	21,335

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Agilent Technologies (BSP:A1GI34) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Agilent Technologies's Liquidation Value for the quarter that ended in Jan. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8597.014	-	23410.632	+	0.75 * 6369.069	+	0.5 * 5080.501
=	-7,497

Agilent Technologies Total Current Assets Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilent Technologies (BSP:A1GI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (BSP:A1GI34) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

A:USA A:Mexico 1A:Italy AG8:Germany

Address

5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051

Website

https://www.agilent.com

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Agilent Technologies (BSP:A1GI34) Headlines

No Headlines